Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. N2EW34
9. INTC
10. IMNN

Go back to Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology

Cogentix Medical (CGNT) Tops Q2 EPS by 2c

August 1, 2017 4:23 PM EDT

Cogentix Medical (NASDAQ: CGNT) reported Q2 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.9 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

... More